Abstract
Background We developed and tested a Centering-based group antenatal (ANC) model in Malawi, integrating health promotion for HIV prevention and mental health. We present effectiveness data and examine congruence with the only Group ANC theory of change model, which identifies key processes as supportive relationships, empowered partners in learning and care, and meaningful services, leading to better ANC experiences and outcomes.
Methods We conducted a hybrid effectiveness-implementation trial at seven clinics in Blantyre District, Malawi, comparing outcomes for 1887 pregnant women randomly assigned to Group ANC or Individual ANC. Group effects on outcomes were summarized and evaluated using t-tests, Mann-Whitney, or Chi-squared tests, and multivariable linear or logistic regression models adjusted for baseline outcomes, seven individual and two clinic-level covariates. All statistical tests were two-sided, controlling for a Type I error probability of 0.01 due to multiple testing.
Findings Women in Group ANC had higher peer connectedness and pregnancy-related empowerment, recalled receiving more services, and discussed more health promotion topics. They experienced less wait time, greater satisfaction with care (Estimate = 1.21, 99% CI = 0.07, 2.35), had a higher mean number of ANC contacts (Estimate = 0.74, 99% CI = 0.50, 0.98), and were more likely to complete at least four or eight contacts. Most women preferred Group ANC for a future pregnancy (81% in Individual ANC; 95% in Group ANC). Women in Group ANC had more diverse diets (Estimate = 0.35, 99% CI = 0.17, 0.53), were better prepared for birth (Estimate 0.32, 99% CI = 0.16, 0.48), more likely to use condoms consistently (OR= 1.07, 99% CI = 1.00, 1.14) and communicated more with partners. They reported less mental distress in late pregnancy (Estimate = -0.61, 99% CI = -1.20, -0.02). Exclusive breastfeeding, partner HIV testing and disclosure, facility-based delivery, postnatal care attendance, postpartum family planning, and low birth weight did not differ by ANC type.
Conclusions This effectiveness study of Malawi Group ANC, the first trial with individual randomization in a low-income country, maps outcomes to the theory of change, enhancing our understanding of Group ANC’s diverse positive impacts. The integration of typically neglected health promotion topics highlights group care’s flexibility to address local and global needs. Based on study results, the Malawi Ministry of Health is introducing Group ANC at district-level trainings and exploring the logistics for nationwide adoption. With momentum and political will, we are poised to bring better care and a positive healthcare experience to women, infants, and families throughout Malawi and globally.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This trial is registered at ClinicalTrials.gov under registration number NCT03673709, registered on September 17, 2018. https://clinicaltrials.gov/study/NCT03673709
Clinical Protocols
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8276-x
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The procedures and ethical conduct of the This study was approved by the Institutional Research Boards at the University of Illinois Chicago (IRB: 2018-0845), University of Michigan (HUM00243435), and Kamuzu University of Health Sciences (COMREC: P.10/18/2498).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Trial registration This trial is registered at ClinicalTrials.gov under registration number NCT03673709, registered on September 17, 2018.
Data Availability
The data underlying the results presented in the study are available from https://deepblue.lib.umich.edu/data